Literature DB >> 32576404

Botulinum toxin to avoid component separation in midline large hernias.

José Bueno-Lledó1, Jesús Martinez-Hoed2, Antonio Torregrosa-Gallud2, Miriam Menendez-Gimenez2, Salvador Pous-Serrano2.   

Abstract

BACKGROUND: The goal of our study was to compare results in patients with large midline incisional hernia using modified anterior component separation versus preoperative botulinum toxin and following Rives repair, with a focus on surgical site occurrences, possibility of fascial closure, duration of hospital stay, and hernia recurrence rate.
METHODS: From to March 2016 to June 2019, a prospective comparative study was performed in 80 consecutive patients with large midline incisional hernias and hernia transverse diameters between 11 and 17 cm under elective hernia repair at our tertiary center. Two groups were analyzed prospectively: 40 patients with preoperative botulinum toxin administration and following open Rives repair (botulinum toxin group) were compared with 40 patients who underwent open component separation during that period (component separation group).
RESULTS: All large midline incisional hernias were classified W3, with mean transverse and longitudinal defect diameters of 14.9 cm (11.8-16.5) and 24 cm (11-28), respectively. Complete fascial closure was possible in all patients in the preoperative botulinum toxin group. No complications occurred during the administration of preoperative botulinum toxin, but surgical site complications were most frequent in the component separation group, especially skin necrosis (12.5%, P = .020). At a median of 19.6 months (range, 11-35) of postoperative follow-up, 2 cases of hernia recurrence (8.9%) were reported, all of them in the component separation group.
CONCLUSION: Botulinum toxin allows getting a successful downstaging from surgical repair to Rives technique in patients with large midline incisional hernia, especially with hernia transverse diameters between 11 and 17 cm. These results contribute to minimize disadvantages associated to the anterior component separation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32576404     DOI: 10.1016/j.surg.2020.04.050

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

Review 1.  Prehabilitation of complex ventral hernia patients with Botulinum: a systematic review of the quantifiable effects of Botulinum.

Authors:  J A Wegdam; T S de Vries Reilingh; N D Bouvy; S W Nienhuijs
Journal:  Hernia       Date:  2020-11-19       Impact factor: 4.739

2.  Adjunct botox to preoperative progressive pneumoperitoneum for incisional hernia with loss of domain: no additional effect but may improve outcomes.

Authors:  A Tashkandi; J Bueno-Lledó; J Durtette-Guzylack; A Cayeux; R Bukhari; R Rhaeim; J M Malinovski; R Kianmanesh; Y Renard
Journal:  Hernia       Date:  2021-03-09       Impact factor: 4.739

3.  Editorial: Botox in Complex Abdominal Wall Surgery.

Authors:  Jose Bueno-Lledo; Nabeel Ibrahim; Martin Zielinski
Journal:  Front Surg       Date:  2022-04-18

4.  Bridged repair of large ventral hernia defects using an ovine reinforced biologic: A case series.

Authors:  George DeNoto
Journal:  Ann Med Surg (Lond)       Date:  2022-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.